Psoriasis and pregnancy outcomes in biological therapies: a real-life, multi-center experience.

We performed a retrospective study including 307 psoriatic women of childbearing age treated with biologics in 5 Dermatologic Center of University Hospitals (Modena, Bologna, Reggio Emilia, Parma, Ferrara) from 2004 to 2019. We defined the pregnancy exposed to biological drugs if the woman had at least one administration during pregnancy: we identified 14 pregnancies in 12 women. Patients has been treated with a biological drug since 35 ± 24 months at time of conception. None of them experienced AE during treatment. This article is protected by copyright. All rights reserved.